Cancer Clinical Trial
Official title:
BETTER Women: Community-Based, Primary Care-Linked Peer Health Coaching to Achieve Evidence-Based Preventive Care Goals - A Pragmatic, Wait-List Controlled Effectiveness-Implementation Trial
NCT number | NCT04746859 |
Other study ID # | 2020-0079-E |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 14, 2021 |
Est. completion date | April 2024 |
The Building on Existing Tools To improvE cancer and chronic disease pRevention and screening in primary care (BETTER) Program allows patients in primary care to have a dedicated visit with a prevention practitioner to discuss chronic disease prevention and cancer screening. A prevention practitioner is a health professional, working in primary care, who has received additional training to discuss chronic disease prevention and screening and develop health goals with patients through shared decision-making. Previous studies have shown that this approach increases the number of prevention and screening actions completed by program participants. However, maintenance of health behaviour changes is difficult without on-going support. There is also some evidence that peer-delivered coaching can improve health outcomes in community settings. As such, the BETTER Women program extends the BETTER program by focusing on 40 to 68-year-old women and providing time-limited support for health behaviour change through peer health coaches. Coaches are volunteers - trained in techniques to support health behaviour change - who support women to achieve their health goals over a 6-month period. In this study, the investigators will explore: (i) whether patients who participate in health coaching after a prevention visit are more likely to increase the number of prevention and screening actions that they complete after six months, compared to women who participate in a prevention visit but do not get health coaching; (ii) whether the intervention effects endure six months after the intervention ends; and (iii) the implementation of the program to learn about factors that affect various aspects of the success and sustainability of the program.
Status | Recruiting |
Enrollment | 408 |
Est. completion date | April 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 68 Years |
Eligibility | Inclusion Criteria: - Patient identifies as a woman; - Patient is 40-68yo; - Patient has an email address; - Patient has at least one behavioural risk factor not at target or at least one cancer screening overdue as defined below: - Score of less than 9 on the Mediterranean Diet Tool - Less than 150 minutes of moderate to vigorous physical activity per week - Smoked a cigarette within the last 30 days - Average number of drinks per day is =1 and/or has >1 drink on any single occasion - Due or overdue for one or more of breast, cervical or colorectal cancer screenings; - Patient has a valid number for the provincial health insurance program (Ontario Health Insurance Program [OHIP]); and - Patient's medical records for, at least the previous 3 years are accessible through their family physician. Exclusion Criteria: - Patient is unable to give informed consent in English due to language, literacy, or competence; - Patient is unable or unwilling to communicate with the study team to collect outcomes in English via both email and phone; or - Patient's primary care provider has identified medical comorbidities or other conditions at baseline that might interfere with the patient's ability to follow through on the intervention. |
Country | Name | City | State |
---|---|---|---|
Canada | Barrie and Community Family Health Team | Barrie | Ontario |
Canada | Summerville Family Health Team | Mississauga | Ontario |
Canada | Women's College Hospital Family Practice Health Centre | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
Women's College Hospital | Applied Health Research Centre, Barrie and Community Family Health Team, Canadian Cancer Society (CCS), Public Health Agency of Canada (PHAC), Summerville Family Health Team, University Health Network, Toronto, Women's College Hospital Family Practice Health Centre, Women's College Hospital Foundation |
Canada,
Bodenheimer TS, Smith MD. Primary care: proposed solutions to the physician shortage without training more physicians. Health Aff (Millwood). 2013 Nov;32(11):1881-6. doi: 10.1377/hlthaff.2013.0234. — View Citation
Grunfeld E, Manca D, Moineddin R, Thorpe KE, Hoch JS, Campbell-Scherer D, Meaney C, Rogers J, Beca J, Krueger P, Mamdani M; BETTER Trial Investigators. Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Fam Pract. 2013 Nov 20;14:175. doi: 10.1186/1471-2296-14-175. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cardiovascular risk | 10-year cardiovascular risk | 0, 6 months; 12 months for intervention group only | |
Other | Health-related quality of life | Health utility score based on European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L) health state | 0, 3, 6 months; 12 months for intervention group only | |
Other | Quality-adjusted life year (QALY) | An estimation of the combined health utility values derived from responses from EQ-5D-5L and length of life experienced by patient, between measurement time points | 0, 3, 6 months; 12 months for intervention group only | |
Other | Outpatient visits | Number of times patient accessed publicly funded outpatient healthcare services (e.g., visit to primary care physician, outpatient hospital-based services) while enrolled in the study | 6 months | |
Other | Emergency room (ER) visits | Number of times patient accessed publicly funded healthcare services from a hospital emergency room while enrolled in the study | 6 months | |
Other | Total healthcare costs | The total cost of publicly funded healthcare utilization (outside of delivery of the intervention) by patient while enrolled in the study | 6 months | |
Other | Intervention cost/patient | Incremental cost of the intervention (i.e., delivery of peer health coaching only) per patient | 4 years | |
Other | Duration of intervention effect | This outcome is ordinal and calculated *only for intervention group patients*. It represents the nature of the change in the number of completed targeted behaviours from end of intervention (at 6 months) to end of follow-up (at 12 months). The targeted behaviours include the status (meeting evidence-based target or not) of four behavioural determinants for risk of cancer and chronic disease (diet, smoking, alcohol use, physical activity). If a patient meets more targets at 12 months compared to 6 months, the patient will be said to have improved. If the same number of targets are met, the patient will be said to be unchanged. If fewer targets are met, the patient will be said to have worsened. | 6, 12 months | |
Primary | Increased targeted behaviours from baseline | The primary outcome is binary and defined as whether a patient increased the number of completed targeted behaviours from baseline to end of follow-up at 6 months. The targeted behaviours include the status (up to date or out of date) of three cancer screening tests (cervical, breast, colorectal) and the status (meeting evidence-based target or not) of four behavioural determinants for risk of cancer and chronic disease (diet, smoking, alcohol use, physical activity). If a patient meets at least one more target at 6 months than they met at baseline, their outcome will be considered positive. | 0, 6 months | |
Secondary | Goal achievement | Percentage of patient-set health goals that was achieved | 0, 6 months; 12 months for intervention group only | |
Secondary | Breast cancer screening status | Binary assessment of whether the patient is up to date on their breast cancer screening, as per their history and level of risk | 0, 6 months | |
Secondary | Cervical cancer screening status | Binary assessment of whether the patient is up to date on their cervical cancer screening, as per their history and level of risk | 0, 6 months | |
Secondary | Colorectal cancer screening status | Binary assessment of whether the patient is up to date on their colorectal cancer screening, as per their history and level of risk | 0, 6 months | |
Secondary | Diet status | Binary assessment of whether the patient's Mediterranean Diet Score is at target (=9) | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Improvement in diet | Binary assessment of whether there was an evidence-based improvement (change =2) in diet between assessment points | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Diet management | Binary assessment of whether patient took at least one meaningful action towards diet management | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Physical activity status | Binary assessment of whether time (in minutes) spent doing moderate to vigorous physical activity in the last seven days is at the evidence-based target (=150minutes) | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Improvement in physical activity | Binary assessment of whether or not there was improvement in the physical activity index (PAI) between assessment points | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Physical activity management | Binary assessment of whether patient took at least one meaningful action towards physical activity management | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Smoking status | Binary assessment of whether smoking status meets the target of abstinent for the last 30 days | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Improvement in smoking | Binary assessment of whether the patient's cigarette consumption category, based on consumption of cigarettes per day (cpd), has improved (i.e., cpd decreased) between assessment points | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Smoking management | Binary assessment of whether patient took at least one meaningful action towards management of smoking behaviour | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Alcohol use status | Binary assessment of whether alcohol use is at evidence-based target, i.e., number of drinks per day is <1 and never having =1 drink on one occasion | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Improvement in alcohol use | Binary assessment of whether AUDIT risk category has improved (i.e., risk level has decreased) between assessment points | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Alcohol use management | Binary assessment of whether patient took at least one meaningful action towards management of alcohol use | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Up-to-date measurement of glycated haemoglobin (HbA1c) | Binary assessment of whether the latest HbA1c measurement is up to date at study end, as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | HbA1c control | Binary assessment of whether the latest measurement, at study end, is up to date and at target (<7%) | 0, 6 months; 12 months for intervention group only | |
Secondary | HbA1c | The most recent and up to date HbA1c measurement for patients with diabetes mellitus (DM) | 0, 6 months; 12 months for intervention group only | |
Secondary | Glycemic management | Binary assessment of whether patient with DM (HbA1c not at target) has taken any meaningful actions towards management of blood sugar through initiation of new antihyperglycemic medication, up-titration of existing antihyperglycemic medications, or discussion with healthcare professional regarding behavioural changes needed to improve blood sugar | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Up-to-date measurement of blood pressure (BP) | Binary assessment of whether the latest BP measurement is up to date, as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | BP control | Binary assessment of whether the most recent measurement is up to date and at target as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | Systolic BP | The most recent and up to date systolic BP measurement | 0, 6 months; 12 months for intervention group only | |
Secondary | Diastolic BP | The most recent and up to date diastolic BP measurement | 0, 6 months; 12 months for intervention group only | |
Secondary | Hypertension management | Binary assessment of whether patient with BP not at target has taken at least one action towards management of hypertension through initiation of new blood pressure medication, up-titration of existing blood pressure medication, or discussion with healthcare professional regarding behavioural changes needed to improve blood pressure | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Up-to-date assessment of low-density lipoprotein (LDL) cholesterol | Binary assessment of whether the latest LDL measurement is up to date, as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | LDL control | Binary assessment of whether the most recent LDL measurement is up to date and at target as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | LDL | The most recent and up to date LDL measurement | 0, 6 months; 12 months for intervention group only | |
Secondary | LDL cholesterol management | Binary assessment of whether patient with LDL not at target has taken at least one action towards management of LDL through initiation of new LDL medication, up-titration of existing LDL medication, or discussion with healthcare professional regarding behavioural changes needed to improve cholesterol | 0, 3, 6 months; 12 months for intervention group only | |
Secondary | Up-to-date assessment for obesity | Binary assessment of whether body mass index (BMI) calculation or waist circumference (WC) measurement is up to date, as per patient's characteristics | 0, 6 months; 12 months for intervention group only | |
Secondary | BMI control | Binary assessment of whether latest, up to date BMI is within target (= 30kg/m2) | 0, 6 months; 12 months for intervention group only | |
Secondary | Management of obesity | Binary assessment of whether patient with BMI not at target took any meaningful actions towards management of obesity through use of medication or discussion with healthcare professional regarding behavioural changes needed to manage obesity | 0, 3, 6 months; 12 months for intervention group only |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|